<?xml version="1.0" encoding="utf-8"?>
<rss version="2.0"><channel><title>Yahoo! Finance: AIOAF.PK News</title><copyright>Copyright (c) 2009 Yahoo! Inc. All rights reserved.</copyright><link>http://finance.yahoo.com/q/h?s=aioaf.pk</link><description>Latest Financial News for ANTISOMA (LONDON)</description><language>en-us</language><lastBuildDate>Mon, 7 Dec 2009 07:07:00 Etc/GMT</lastBuildDate><image><url>http://us.news2.yimg.com/us.yimg.com/p/fi/pr/40197.gif</url><title>Yahoo! Finance</title><link>http://finance.yahoo.com</link><width>144</width><height>17</height></image><item><title>AS1413 regimen yields high response rate and durable responses in patients with secondary AML, a poor-risk population underserved by current treatment options (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091207/0566143.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1342153412</guid><pubDate>Mon, 7 Dec 2009 07:07:00 Etc/GMT</pubDate></item><item><title>Antisoma AGM update and Interim Management Statement (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091110/0557286.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/352142173</guid><pubDate>Tue, 10 Nov 2009 07:07:00 Etc/GMT</pubDate></item><item><title>Antisoma&apos;s AS1411 gains US and EU Orphan Drug Status for acute myeloid leukaemia (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091013/0546673.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3807596577</guid><pubDate>Tue, 13 Oct 2009 06:01:00 Etc/GMT</pubDate></item><item><title>Annual Report and Accounts 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091009/0545924.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/1424306542</guid><pubDate>Fri, 9 Oct 2009 08:27:00 Etc/GMT</pubDate></item><item><title>Antisoma to amend ACCEDE phase III study of AS1413 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/091008/0545521.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2583225266</guid><pubDate>Thu, 8 Oct 2009 06:01:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at the UBS Global Life Sciences Conference in New York (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090918/0538571.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/510001088</guid><pubDate>Fri, 18 Sep 2009 11:00:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at the Bank of America Merrill Lynch Global Healthcare Conference in London (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090916/0537684.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/406141100</guid><pubDate>Wed, 16 Sep 2009 06:07:00 Etc/GMT</pubDate></item><item><title>Antisoma&apos;s preliminary results for the year ended 30 June 2009 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090914/0536769.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4231749459</guid><pubDate>Mon, 14 Sep 2009 15:54:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at the Rodman &amp; Renshaw Healthcare Conference in New York (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090903/0533888.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/3796353143</guid><pubDate>Thu, 3 Sep 2009 11:06:00 Etc/GMT</pubDate></item><item><title>Phase III trial of ASA404 in lung cancer completes patient enrolment (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090901/0532870.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2385585792</guid><pubDate>Tue, 1 Sep 2009 06:07:00 Etc/GMT</pubDate></item><item><title>Antisoma and Bryan Oncor announce deal for anti-cancer drug P2045 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090811/0526763.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2729362936</guid><pubDate>Tue, 11 Aug 2009 11:06:00 Etc/GMT</pubDate></item><item><title>Antisoma announces discontinuation of development of AS1402 (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090807/0525978.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2746343566</guid><pubDate>Fri, 7 Aug 2009 14:59:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at the Canaccord Adams 29th Annual Global Growth Conference in Boston (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090805/0524976.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2527692345</guid><pubDate>Wed, 5 Aug 2009 11:06:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at Piper Jaffray Europe Conference in London (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090618/0511860.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/1802720058</guid><pubDate>Thu, 18 Jun 2009 11:06:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at 3rd Annual Jefferies Healthcare Conference in New York (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090615/0510523.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/3789685930</guid><pubDate>Mon, 15 Jun 2009 11:13:00 Etc/GMT</pubDate></item><item><title>Antisoma to present at 8th Annual Needham Life Sciences Conference in New York (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090605/0508065.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/3839468999</guid><pubDate>Fri, 5 Jun 2009 11:01:00 Etc/GMT</pubDate></item><item><title>Antisoma&apos;s AS1409 shows anti-cancer activity in phase I trial (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090531/0506154.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/4052163961</guid><pubDate>Sun, 31 May 2009 18:13:00 Etc/GMT</pubDate></item><item><title>Antisoma to advance AS1411 in AML based on positive phase II data presented at ASCO (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090529/0505918.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/2743831375</guid><pubDate>Fri, 29 May 2009 18:11:00 Etc/GMT</pubDate></item><item><title>Phase II trial of ASA404 published in Lung Cancer (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090521/0503593.html?.v=1</link><description></description><guid isPermaLink="false">yahoo_finance/3805453046</guid><pubDate>Thu, 21 May 2009 06:01:00 Etc/GMT</pubDate></item><item><title>Antisoma sells oral fludarabine to sanofi-aventis U.S. for USD 65 million (Marketwire)</title><link>http://us.rd.yahoo.com/finance/news/rss/story/*http://biz.yahoo.com/iw/090512/0500197.html?.v=2</link><description></description><guid isPermaLink="false">yahoo_finance/142499546</guid><pubDate>Tue, 12 May 2009 05:05:00 Etc/GMT</pubDate></item></channel></rss><!-- c8.finance.sp2.yahoo.com compressed/chunked Tue Dec 22 06:57:39 PST 2009 -->
